SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-06-008743
Filing Date
2006-01-19
Accepted
2006-01-19 16:43:47
Documents
2
Effectiveness Date
2006-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm DEFA14A 18120
2 AMENDMENT NO. 1 TO THE STOCK PURCHASE AGREEMENT dex21.htm EX-2.1 13600
  Complete submission text file 0001193125-06-008743.txt   33009
Mailing Address
Business Address 1124 COLUMBIA STREET SUITE 130 SEATTLE WA 98104 2062626200
XCYTE THERAPIES INC (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: WA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-50626 | Film No.: 06538648
SIC: 2834 Pharmaceutical Preparations